US FDA approves UCB’s 320 mg single-injection device presentations of Bimzelx: Brussels, Belgium Tuesday, October 15, 2024, 13:00 Hrs [IST] UCB, a global biopharmaceutical compa ...
Arthritis in your 20s might seem unusual, but it's becoming more frequent. Check out these 7 warning signs and symptoms of ...
Individuals with self-reported moderate to severe psoriatic arthritis (PsA) face a higher disease burden, particularly among ...
Imuldose will be marketed in the United States by Accord BioPharma and is expected to launch in the first half of 2025.
PRNewswire Ahmedabad Gujarat [India] October 14 Accord BioPharma Inc the US specialty division of Intas Pharmaceuticals Ltd ...
HealthDay on MSN22h
Health Tip: Keep Psoriatic Arthritis Fatigue in CheckFatigue is a common problem for people with psoriatic arthritis. According to the National Psoriasis Foundation, some studies indicate that half of all psoriatic arthritis patients have ...
HealthDay on MSN22h
Health Tip: Do You Have Psoriatic Arthritis?Psoriatic arthritis is an inflammatory joint condition that is associated with the chronic skin condition psoriasis. The Arthritis Foundation says common symptoms of psoriatic arthritis include: ...
Dong-A ST's biosimilar product Imuldosa has been approved by the U.S. Food and Drug Administration (FDA), the Korean ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback